{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:57:06Z","timestamp":1775483826977,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200805"],"award-info":[{"award-number":["82200805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clnesp.2025.01.041","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T09:13:01Z","timestamp":1737709981000},"page":"290-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The predictive value of triglyceride-glucose-high density lipoprotein-body mass index (TGH-BMI) for different degrees of hepatic steatosis and liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD)"],"prefix":"10.1016","volume":"66","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianrong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6002-9477","authenticated-orcid":false,"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clnesp.2025.01.041_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"1 Suppl","key":"10.1016\/j.clnesp.2025.01.041_bib2","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.01.041_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.01.041_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.clnesp.2025.01.041_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/chi.2022.0048","article-title":"Nonalcoholic fatty liver disease in young children with obesity","volume":"19","author":"Klepper","year":"2023","journal-title":"Child Obes (Print)"},{"issue":"5","key":"10.1016\/j.clnesp.2025.01.041_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MCO.0000000000000849","article-title":"Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicine","volume":"25","author":"Perez-Diaz-Del-Campo","year":"2022","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"10.1016\/j.clnesp.2025.01.041_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.clnesp.2025.01.041_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11901-017-0378-2","article-title":"Natural history of NAFLD\/NASH","volume":"16","author":"Ekstedt","year":"2017","journal-title":"Current hepatology reports"},{"issue":"10","key":"10.1016\/j.clnesp.2025.01.041_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.12.026","article-title":"Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study","volume":"18","author":"Baratta","year":"2020","journal-title":"Clin Gastroenterol Hepatol : the official clinical practice journal of the American Gastroenterological Association"},{"issue":"5","key":"10.1016\/j.clnesp.2025.01.041_bib10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/jgh.14856","article-title":"Non-alcoholic fatty liver disease and the incidence of myocardial infarction: a cohort study","volume":"35","author":"Sinn","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.clnesp.2025.01.041_bib11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.14309\/ajg.0000000000000484","article-title":"Disease severity is associated with higher healthcare utilization in nonalcoholic steatohepatitis medicare patients","volume":"115","author":"S","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.clnesp.2025.01.041_bib12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/apm.12742","article-title":"Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study","volume":"125","author":"Rastogi","year":"2017","journal-title":"APMIS : APMIS (Acta Pathol Microbiol Immunol Scand)"},{"key":"10.1016\/j.clnesp.2025.01.041_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.21037\/tgh.2020.04.01","article-title":"Evolution of the liver biopsy and its future","volume":"6","author":"Jain","year":"2021","journal-title":"Trans Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.01.041_bib14","first-page":"153","article-title":"The triglyceride-glucose index as an indicator of insulin resistance and cardiometabolic risk in Brazilian adolescents","volume":"67","author":"Reckziegel","year":"2023","journal-title":"Archives Endocrinol Metabol"},{"issue":"9","key":"10.1016\/j.clnesp.2025.01.041_bib15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/s41372-022-01586-0","article-title":"Can the triglyceride-glucose index predict insulin resistance in LGA newborns?","volume":"43","author":"Kavurt","year":"2023","journal-title":"J\u00a0Perinatol : Official J California Perinatal Association"},{"issue":"7","key":"10.1016\/j.clnesp.2025.01.041_bib16","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1210\/jc.2010-0288","article-title":"The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp","volume":"95","author":"Guerrero-Romero","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.clnesp.2025.01.041_bib17","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","article-title":"TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study","volume":"93","author":"Vasques","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.clnesp.2025.01.041_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3803\/EnM.2019.34.2.179","article-title":"Triglyceride glucose index is superior to the homeostasis model assessment of insulin resistance for predicting nonalcoholic fatty liver disease in Korean adults","volume":"34","author":"Lee","year":"2019","journal-title":"Endocrinol Metabol (Seoul, Korea)"},{"key":"10.1016\/j.clnesp.2025.01.041_bib19","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2147\/DMSO.S316864","article-title":"Association between the triglyceride-glucose index and outcomes of nonalcoholic fatty liver disease: a large-scale health management cohort study","volume":"14","author":"Liu","year":"2021","journal-title":"Diabetes, Metab Syndrome Obes Targets Ther"},{"issue":"1","key":"10.1016\/j.clnesp.2025.01.041_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12944-021-01506-9","article-title":"Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population","volume":"20","author":"Wang","year":"2021","journal-title":"Lipids Health Dis"},{"issue":"3","key":"10.1016\/j.clnesp.2025.01.041_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/met.2020.0109","article-title":"Triglyceride glucose index and related parameters (triglyceride glucose-body mass index and triglyceride glucose-waist circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight\/obesity","volume":"19","author":"Khamseh","year":"2021","journal-title":"Metab Syndr Relat Disord"},{"issue":"7","key":"10.1016\/j.clnesp.2025.01.041_bib22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10654-022-00868-3","article-title":"Lifestyle and metabolic factors for nonalcoholic fatty liver disease: mendelian randomization study","volume":"37","author":"Yuan","year":"2022","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"10.1016\/j.clnesp.2025.01.041_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.11.010","article-title":"Transient elastography through controlled attenuated parameter assisting the stratification of cardiovascular disease risk in NAFLD patients","volume":"45","author":"de Sousa Magalh\u00e3es","year":"2021","journal-title":"Clinics Res Hepatolo Gastroenterol"},{"issue":"8","key":"10.1016\/j.clnesp.2025.01.041_bib24","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.dld.2017.03.013","article-title":"A\u00a0comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B","volume":"49","author":"Xu","year":"2017","journal-title":"Digestive Liver Dis : Official J Italian Soc Gastroenterol Italian Association Study Liver"},{"issue":"4","key":"10.1016\/j.clnesp.2025.01.041_bib25","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s11695-024-07106-7","volume":"34","author":"Sharma","year":"2024","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnesp.2025.01.041_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110557","article-title":"Comparison of visual transient elastography, vibration controlled transient elastography, shear wave elastography and sound touch elastography in chronic liver disease assessment using liver biopsy as 'gold standard'","volume":"157","author":"Gatos","year":"2022","journal-title":"Eur J Radiol"},{"issue":"9","key":"10.1016\/j.clnesp.2025.01.041_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/nu16091310","article-title":"Triglyceride to HDL cholesterol ratio for the identification of MASLD in obesity: a liver biopsy-based case-control study","volume":"16","author":"Mart\u00ednez-Montoro","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clnesp.2025.01.041_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12944-019-0986-7","article-title":"Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study","volume":"18","author":"Fan","year":"2019","journal-title":"Lipids Health Dis"},{"issue":"3","key":"10.1016\/j.clnesp.2025.01.041_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000696","article-title":"Reply: a multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Lazarus","year":"2024","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"3","key":"10.1016\/j.clnesp.2025.01.041_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2023.2289830","article-title":"Curative role of natural PPAR\u03b3 agonist in non-alcoholic fatty liver disease (NAFLD)","volume":"12","author":"Singh","year":"2024","journal-title":"Tissue Barriers"},{"issue":"9","key":"10.1016\/j.clnesp.2025.01.041_bib31","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/dom.14076","article-title":"Intrahepatic fat, irrespective of ethnicity, is associated with reduced endogenous insulin clearance and hepatic insulin resistance in obese youths: a cross-sectional and longitudinal study from the Yale Pediatric NAFLD cohort","volume":"22","author":"Tric\u00f2","year":"2020","journal-title":"Diabetes Obes Metabol"},{"issue":"5","key":"10.1016\/j.clnesp.2025.01.041_bib32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.clnesp.2025.01.041_bib33","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.clnesp.2025.01.041_bib34","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J\u00a0Clin Invest"},{"issue":"24","key":"10.1016\/j.clnesp.2025.01.041_bib35","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.96.24.13656","article-title":"Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes","volume":"96","author":"Shimomura","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.clnesp.2025.01.041_bib36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2025.01.041_bib37","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2147\/DMSO.S437811","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease (NAFLD) in non-obese patients with schizophrenia: a retrospective study","volume":"17","author":"Yi","year":"2024","journal-title":"Diabetes, Metab Syndrome Obes Targets Ther"},{"issue":"11","key":"10.1016\/j.clnesp.2025.01.041_bib38","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/2047487320914756","article-title":"HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies","volume":"27","author":"Zhong","year":"2020","journal-title":"Eur J Preven Cardiol"},{"issue":"9","key":"10.1016\/j.clnesp.2025.01.041_bib39","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.numecd.2021.06.004","article-title":"HDL-C, longitudinal change and risk of mortality in a Chinese cohort study","volume":"31","author":"Yang","year":"2021","journal-title":"Nutr Metabol Cardiovasc Dis : NMCD"},{"issue":"4","key":"10.1016\/j.clnesp.2025.01.041_bib40","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1097\/MPG.0000000000002825","article-title":"Adiponectin is increased in pediatric patients with autoimmune hepatitis independent of body weight","volume":"71","author":"Cortez","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2025.01.041_bib41","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3945\/ajcn.2008.27336","article-title":"Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes","volume":"89","author":"L\u00ea","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"10.1016\/j.clnesp.2025.01.041_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15112871","article-title":"Cellular and molecular mechanisms of liver fibrosis in patients with NAFLD","volume":"15","author":"Sanchez","year":"2023","journal-title":"Cancers"},{"issue":"7698","key":"10.1016\/j.clnesp.2025.01.041_bib43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nature26138","article-title":"Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance","volume":"555","author":"Ghorpade","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.clnesp.2025.01.041_bib44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2022.10.034","article-title":"Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores","volume":"78","author":"Sanyal","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.01.041_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100774","article-title":"New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD","volume":"28","author":"Torres","year":"2023","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.clnesp.2025.01.041_bib46","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.aohep.2020.08.066","article-title":"Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population","volume":"19","author":"Zambrano-Huailla","year":"2020","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.clnesp.2025.01.041_bib47","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/hep.23593","article-title":"Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study","volume":"51","author":"Speliotes","year":"2010","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"5","key":"10.1016\/j.clnesp.2025.01.041_bib48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-144-5-200603070-00022","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"144","author":"Kida","year":"2006","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.clnesp.2025.01.041_bib49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic fatty liver disease and serum lipoproteins: the multi-ethnic study of atherosclerosis","volume":"227","author":"DeFilippis","year":"2013","journal-title":"Atherosclerosis"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725000427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725000427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T17:11:55Z","timestamp":1741972315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725000427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":49,"alternative-id":["S2405457725000427"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.01.041","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The predictive value of triglyceride-glucose-high density lipoprotein-body mass index (TGH-BMI) for different degrees of hepatic steatosis and liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD)","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.01.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}